Bivalirudin Monitoring Using Dilute Thrombin Time in Pediatric Extracorporeal Membrane Oxygenation: Single-Center, Retrospective Cost Analysis, 2018–2023
From 2018 to 2023, use of dTT monitoring for bivalirudin, rather than aPTT monitoring for UFH, during ECMO was associated with decreased laboratory testing and costs and is available on an automated or semi-automated platform. Overall, our data support the use of dTT-monitored bivalirudin during ECMO support, which is cost-efficient and may lead to reduction in total laboratory testing and blood volume sampling.
Authors
- Tanya Perry (ORCID: https://orcid.org/0000-0001-7002-1155)
- Elissa Engel (ORCID: https://orcid.org/0000-0002-8604-5511)
- L DORN
- Lori Luchtman-Jones
- Karen Flint
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Cohen Children's Medical Center (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Pediatric Critical Care Medicine
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1097/pcc.0000000000003938
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 21.28